Giulio Pierleoni

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response

R. Rappuoli, D. Medini, R. De Francesco, 2023, Nature Communications.

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations

R. Rappuoli, A. Ruello, A. Manenti, 2022, Communications Biology.

mRNA vaccines and hybrid immunity use different B cell germlines to neutralize Omicron BA.4 and BA.5

R. Rappuoli, P. Maes, D. Medini, 2022, bioRxiv.